AstraZeneca and Sandoz resolve Faslodex patent litigation

13-07-2016

AstraZeneca announced today that it has entered into an agreement with Sandoz to resolve patent litigation between the two companies.


AstraZeneca, Sandoz, agreement, patent, Faslodex, fulvestrant

More on this story

Patent litigation: a global perspective
11-05-2021

LSIPR